Media
Read more about our latest media appearances, press releases and published articles that shine a spotlight on our work and innovations.
​
Explore our latest posts on LinkedIn where we share news, insights and updates on our activities and progress.
Currently on LinkedIn
Here you will find our latest posts on LinkedIn where we share news, insights and updates about our activities and progress.
Press releases
​
​
​
Articles
Article Dietisten 2023-11-21. About how Evira is used BUMM Norrtälje. https://www.dietisten.net/artiklar/Obesitas/matplatta-bra-vid-overvikt-och-obesitas-hos-barn
​
https://nyheter.ki.se/mobilapp-effektivt-stod-for-barn-med-obesitas
​
https://medtech4health.se/evira-ett-digitalt-verktyg-for-behandling-av-barnfetma/
​
https://sophianytt.se/artiklar/bast-pa-obesitasbehandling/
https://www.dn.se/sverige/fetma-bland-barn-okade-under-pandemin/
​
Participation in podcasts, etc
[SWEDISH] En Tyngre podd! 2024-04-21. Episode 65. Digitisation of childhood obesity treatment, how does it work? Malin Ramkloo.
​​
​​
Published research
”Effect of an interactive mobile health support system and daily weight measurements for pediatric obesity treatment, a one-year pragmatical clinical trial”, Emilia Hagman, Linnea Johansson, Claude Kollin, Erik Marcus, Andreas Drangel, Love Marcus, Claude Marcus, Pernilla Danielsson, International Journal of Obesity, online 31 maj 2022, doi: 10.1038/s41366-022-01146-8.
Thesis for doctoral degree(Ph.D) 2022. Mobile Health interventiopns and cardiorespiratory fitness in pediatric obesity.​Linnea Johansson, Karolinska Institutet.
A novel interactive mobile health support system for pediatric obesity treatment: a randomized controlled feasibility trial. ​Linnea Johansson, Emilia Hagman, Pernilla Danielsson. BMC Pediatr. 2020;20:447.
​
Evira has been used in clinical practice since 2018
Every day, patients and clinical staff use Evira to reduce complications associated with excess weight by decreasing the degree of obesity in children and young people.
4500 +
Patients
Thousands of patients have received, or are receiving, support to manage complications related to excess weight with Evira
1,5 years
Average duration of treatment
1,000,000+
Measurements
One million measurements have been carried out in the safety of the patients' own homes
−0,3
BMI-SDS
7 000+
Years of treatment
Patients have already contributed thousands of treatment years, which we regularly analyse to enhance the tool and the treatment
50
Clinics
This indicates the median and average duration of treatment with Evira, which varies based on factors such as the initial degree of obesity
This shows the average reduction in BMI-SDS (a measure of relative degree of overweight) for a patient after one year of treatment with Evira.
This shows how many clinics have used Evira for the treatment of childhood obesity in five different countries
